European Multicenter Study on Analytical Performance of DxN Veris System HCV Assay
暂无分享,去创建一个
Jordi Vila | Patrick Braun | Rafael Delgado | Alessandra Lombardi | Maria Rita Gismondo | Jacques Izopet | A. Lombardi | M. Gismondo | H. Fleury | J. Izopet | J. Vila | J. Hofmann | P. Trimoulet | P. Braun | R. Delgado | S. O'shea | D. Fanti | K. Sauné | Pascale Trimoulet | Siobhan O'Shea | Hervé Fleury | Maria Angeles Marcos | Monica Drago | Diana Fanti | Jörg Hofmann | Sebastian Kühn | Karine Sauné | Alfredo Pérez-Rivilla | John Ramble | Duncan Whittaker | Alain Artus | Daniel W. Rhodes | M. Marcos | A. Pérez-Rivilla | Daniel Rhodes | M. Drago | Sebastian Kühn | Duncan Whittaker | A. Artus | J. Ramble
[1] John E. Bennett,et al. Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .
[2] P. Pancholi,et al. Performance of the Abbott RealTime and Roche Cobas TaqMan Hepatitis C Virus (HCV) Assays for Quantification of HCV Genotypes , 2012, Journal of Clinical Microbiology.
[3] B. Frémont,et al. SUMMARY OF SAFETY AND EFFECTIVENESS DATA , 2002 .
[4] H. Fleury,et al. Evaluation of the VERSANT HCV RNA 3.0 Assay for Quantification of Hepatitis C Virus RNA in Serum , 2002, Journal of Clinical Microbiology.
[5] H. Masur,et al. Utility of hepatitis C viral load monitoring on direct-acting antiviral therapy. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] Aasld Idsa Hcv Guidance Panel. Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus , 2015, Hepatology.
[7] B. Gärtner,et al. Differences between Two Real-Time PCR-Based Hepatitis C Virus (HCV) Assays (RealTime HCV and Cobas AmpliPrep/Cobas TaqMan) and One Signal Amplification Assay (Versant HCV RNA 3.0) for RNA Detection and Quantification , 2008, Journal of Clinical Microbiology.
[8] G. Colucci,et al. Improved COBAS TaqMan Hepatitis C Virus Test (Version 2.0) for Use with the High Pure System: Enhanced Genotype Inclusivity and Performance Characteristics in a Multisite Study , 2007, Journal of Clinical Microbiology.
[9] M. Ghany,et al. Diagnosis, management, and treatment of hepatitis C: An update , 2009, Hepatology.
[10] Roger Williams. Global challenges in liver disease , 2006, Hepatology.
[11] J. Pawlotsky,et al. Performance of the Abbott Real-Time PCR Assay Using m2000sp and m2000rt for Hepatitis C Virus RNA Quantification , 2009, Journal of Clinical Microbiology.
[12] H. Rosen. Clinical practice. Chronic hepatitis C infection. , 2011, The New England journal of medicine.
[13] S. Zeuzem,et al. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. , 2011, Journal of hepatology.